Biotech News
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
ir.cvrx.com2026-05-06 15:02 EST
MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, confirmed today that Category I